Johanna Inhestern

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

J. Guigay, Anne Aupérin, Jérôme Fayette et al. · The Lancet Oncology · 2021 · 214 citations

Gortec 2014-01 Tpextreme, Neoadjuvant Therapy, Medicine +11

International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ‐HN43: Phase IV

Susanne Singer, Cecilie Delphin Amdal, Eva Hammerlid et al. · Head & Neck · 2019 · 130 citations · Full text

Prognostic Role of Circulating Tumor Cells during Induction Chemotherapy Followed by Curative Surgery Combined with Postoperative Radiotherapy in Patients with Locally Advanced Oral and Oropharyngeal Squamous Cell Cancer

Johanna Inhestern, Katrin Oertel, Viola Stemmann et al. · PLoS ONE · 2015 · 69 citations · Full text

Quality of Life in Patients With Hypoparathyroidism After Treatment for Thyroid Cancer

Matthias Büttner, Laura D. Locati, Monica Pinto et al. · The Journal of Clinical Endocrinology & Metabolism · 2020 · 53 citations · Full text

The EORTC module for quality of life in patients with thyroid cancer: phase III

Susanne Singer, Susan J. Jordan, Laura D. Locati et al. · Endocrine Related Cancer · 2017 · 48 citations · Full text